DNA Script inks $200m Series C

DNA Script, a provider of enzymatic DNA synthesis for on-demand DNA printing, has raised $200 million in Series C financing.

4 January 2022•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles